Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-27

Clinical Trial Update: Rivastigmine and Huperzine A as Treatments for Cocaine Dependence [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated rivastigmine and huperzine A as potential treatments for cocaine use disorder, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huperzine A (Huperzine A)
  • Rivastigmine (Rivastigmine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cocaine Dependence, Cocaine Addiction | Phase 1 | Status: COMPLETED